492 results - The Consciousness Library

Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder (opens ClinicalTrials.gov in a new tab)

Withdrawn Phase 2 0 participants Johns Hopkins University

Opioid Use Disorder

Psilocybin for Methamphetamine Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 42 participants Peter Hendricks

Methamphetamine Use Disorder

Inhaled Cannabis for Treatment of PTSD (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 320 participants Multidisciplinary Association for Psychedelic Studies

Post Traumatic Stress Disorder PTSD

Group PACBT for Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants University of California, Los Angeles

Depression - Major Depressive Disorder, Psilocybin, Cognitive Behavioral Therapy

Psilocybin-Assisted Psychotherapy for Veterans With PTSD (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 12 participants ARQ National Psychotrauma Centre

Posttraumatic Stress Disorder (PTSD)

Electrophysiologic Mechanisms of Ketamine Antidepressant Response (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 37 participants Emory University

Epilepsy, Depressive Symptoms

Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 100 participants National Institute on Drug Abuse (NIDA)

Cannabis Use Disorder

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 83 participants M.D. Anderson Cancer Center

Psilocybin, Neuropathy

Psilocybin Therapy for Methamphetamine Use Disorder and HIV (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants Nicky Mehtani, MD, MPH

Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV)

MDMA-AT for PTSD in Young Adults With Childhood Trauma (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 15 participants Jenna M. Traynor

Posttraumatic Stress Disorder (PTSD)

MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 60 participants University of Calgary

Advanced Cancer, Demoralization, Existential Distress, Psychological Distress

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 200 participants National Institute on Aging (NIA)

Alzheimer's Disease

Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 86 participants U.S. Army Medical Research and Development Command

PTSD, Post Traumatic Stress Disorder PTSD, Post Traumatic Stress Disorder

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2/3 105 participants Johns Hopkins University

Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification, Craving

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 30 participants Nautilus Sanctuary

Post-Traumatic Stress Disorder, Adjustment Disorders

Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 45 participants Yale University

Chronic Low Back Pain (CLBP), Physical Therapy, Psilocybin

Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 76 participants University of Calgary

Post Traumatic Stress Disorder PTSD, Intimate Partner Violence (IPV)

Psilocybin Efficacy With or Without Pimavanserin Pretreatment (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 1/2 20 participants Johns Hopkins University

Mood (Psychological Function), Well Being, Mood, Healthy

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2 20 participants Roswell Park Cancer Institute

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

Psilocybin for Treatment of OCD-2 (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants Francisco A Moreno

Obsessive - Compulsive Disorder

Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 2/3 60 participants The Royal's Institute of Mental Health Research

Treatment Resistant Depression, Major Depressive Disorder (MDD)

The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 48 participants Manoj Doss

Healthy

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (opens ClinicalTrials.gov in a new tab)

Recruiting Phase 2/3 300 participants COMPASS Pathways

PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms, PTSD, Post Traumatic Stress Disorder

Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 280 participants Leslie Lundahl

PTSD, Post Traumatic Stress Disorder, Suicide, Cannabis Use

Pregnenolone for Cannabis Use Disorder and Depression (opens ClinicalTrials.gov in a new tab)

Not yet recruiting Phase 1/2 20 participants University of Texas Southwestern Medical Center

Cannabis Use Disorder, Major Depressive Disorder (MDD)